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Abstract
Background: Macrophages are one of the major cell types in innate immunity against microbial infection. It is believed that
the expression of proinflammatory genes such as tumor necrosis factor-a (TNF-a), interleukin (IL)-1b, IL–6, and
cyclooxygenase-2 (Cox-2) by macrophages is also crucial for activation of both innate and adaptive immunities. RNase L
is an interferon (IFN) inducible enzyme which is highly expressed in macrophages. It has been demonstrated that RNase L
regulates the expression of certain inflammatory genes. However, its role in macrophage function is largely unknown.
Methodology: Bone marrow-derived macrophages (BMMs) were generated from RNase L+/+and 2/2 mice. The migration of
BMMs was analyzed by using Transwell migration assays. Endocytosis and phagocytosis of macrophages were assessed by
using fluorescein isothiocyanate (FITC)-Dextran 40,000 and FITC-E. coli bacteria, respectively. The expression of inflammatory
genes was determined by Western Blot and ELISA. The promoter activity of Cox-2 was measured by luciferase reporter
assays.
Conclusions/Findings: Lack of RNase L significantly decreased the migration of BMMs induced by M-CSF, but at a less
extent by GM-CSF and chemokine C-C motif ligand-2 (CCL2). Interestingly, RNase L deficient BMMs showed a significant
reduction of endocytic activity to FITC-Dextran 40,000, but no any obvious effect on their phagocytic activity to FITC-
bacteria under the same condition. RNase L impacts the expression of certain genes related to cell migration and
inflammation such as transforming growth factor (TGF)-b, IL-1b, IL-10, CCL2 and Cox-2. Furthermore, the functional analysis
of the Cox-2 promoter revealed that RNase L regulated the expression of Cox-2 in macrophages at its transcriptional level.
Taken together, our findings provide direct evidence showing that RNase L contributes to innate immunity through
regulating macrophage functions.
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Introduction
Macrophages function in both innate and acquired immune
responses. In tissues, macrophages stand guarding against
pathogen invading and are able to immediately defend and
migrate to the sites of infection as well as present an antigen to the
cells of the adaptive immune system. As a key player in the first
line of defense, macrophages are distributed in all organs, tissues
and fluids throughout the body. Upon triggered by a range of
stimuli including damaged cells, pathogens and cytokines,
macrophages are attracted by chemical substances through
chemotaxis to a damaged or infected site. At the infected tissue
sites, macrophages engulf and digest cellular debris and pathogens,
subsequently activate lymphocytes or other immune cells in
adaptive immunity [1,2]. Macrophages show a great diversity of
phenotypes and functions as a result of what they adapt to the
microenvironment, where macrophages are exposed to particular
tissues, cell types, and physiological states. Thus, macrophages
from different location in the body vary in their maturation,
function, and metabolism as evidenced by their differential
responses to stimulation and displaying of different surface
markers, even the distinct capability of phagocytosis: a hallmark
of macrophage activity. For example skin-associated macrophages
and Langerhans cells are poorly phagocytic. Furthermore, the
expression of receptors, oxidative burst and cytokine production
are markedly variable in macrophage subtypes as well [3–5].
A number of gene products have been found to mediate
macrophage functions. In addition to a pathogen and altered cells,
cytokines such as IFN-c and TNF-a are able to activate
macrophages. The recruitment of macrophages to the inflamma-
tory site is a complex process involving their adhesion to
endothelial cells, traverse of the perivascular connective tissue,
and migration driven by a chemotactic gradient. CCL2, also
known as monocyte chemoattractant protein 1 (MCP-1), is a
member of the cytokine/chemokine superfamily promoting the
migration of monocytes and macrophages to the sites of
inflammation [6]. It has been shown that mice deficient CCL2
decrease recruitment of macrophages in response to infection
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[7,8]. IL-10 is able to facilitate macrophage migration through its
inhibitory effect on macrophage migration inhibitory factor (MIF)
[9,10]. Growth factors such as TGF-b and M-CSF also contribute
to macrophage recruitment at the inflammatory sites and tumor
tissues [11,12]). Interestingly, it has been reported that macro-
phages secret TGF-b, which in turn stimulates their migration
through inducing the expression of CCL2 mediated by RhoA [13].
Cox-2, a key regulator in inflammation, is also involved in
macrophage migration and infiltration. A Cox-2 inhibitor is found
to completely inhibit macrophage migration [14]. In the brain of
patients with Alzheimer’s disease, only Cox-2 positive macro-
phages infiltrate into perivascular spaces and neuropil [15].
RNase L is one of the key enzymes in the 2-5A system of IFN
action against viral infection and cellular proliferation [16,17].
The 2-5A system consists of two enzymes: 2-5A synthetase and
RNase L. IFNs induce the expression of a family of 2-5A
synthetase genes (OAS). Activation of 2-5A synthetases requires
double-stranded RNA (dsRNA), which is frequently produced
during viral infection. After activation by dsRNA, 2-5A synthe-
tases convert ATP molecules to pyrophosphate (ppi) and a series of
unique, 59-phosphorylated, 29-59 linked oligoadenylates known as
2-5A with the general formula of ppp(A29p59)nA (n$2). 2-5A
activates RNase L resulting in degradation of single-stranded viral
and cellular RNAs, leading to inhibition of the replication of
certain viruses and cell proliferation [18–20]. RNase L null mice
show enlarged thymus glands and increased T-cell numbers at the
early age, suggesting that RNase L may be involved in T-cell
development, which likely results from reduced cell apoptosis.
Furthermore, it has been demonstrated that overexpression of
RNase L in the cells enhances cell apoptosis, whereas dominant
negative RNase L suppresses cell apoptosis [21]. These observa-
tions implicate that RNase L may play an important role in the
immune system. Indeed, studies have revealed that skin allograft
rejection is suppressed in mice lacking RNase L, suggesting the
involvement of RNase L in T-cell immunity, particularly CD4+ T-
cell mediated immunity [22]. In addition, alphavirus-based DNA
vaccination against a non-mutated tumor-associated self-antigen
(tyrosinase-related protein-1, TRP-1) is severely impaired in
RNase L null mice, indicating that RNase L plays an important
role in the host immune system against cancer [23].
RNase L is present at basal levels in most mammalian cells.
Tissue distribution analysis has revealed that RNase L is highly
expressed in the spleen, thymus, and most of immune cells such as
T, B cells and macrophages. However, the physiological role of
RNase L in the immune system is largely unknown. In the present
study, we demonstrate that RNase L contributes to macrophage
functions by using BMMs from RNase L deficient and wild type
mice. Furthermore, RNase L regulates the expression of Cox-2,
and certain cytokines and chemokines in macrophages, which in
turn modulates macrophage functions. Taken together, our
findings suggest a novel role of RNase L in innate immunity.
Results
RNase L deficiency reduces macrophage migration
RNase L is highly expressed in macrophages [24]. To determine
the effect of RNase L on macrophage functions, we first examined
the migration of BMMs with or without RNase L under the
influence of different chemotrafficking reagents. In this experi-
ment, BMMs differentiated from the bone marrow cells of RNase
L +/+ and 2/2 mice in serum-free medium were seeded in the
upper chambers of the transwells with a pore size of 8 mm, a
commonly used tool to analyze cell migration. The media in the
lower chambers were supplemented with or without 10% fresh
fetal bovine serum, 100 ng/ml of M-CSF, GM-CSF and CCL2,
respectively. The cells on the upper layer of the membrane
migrated through the micropores on the membrane while sensing
chemoattractants in the lower chamber. After termination of the
experiment, the migrated cells were stained with eosin. As shown
in Figure 1A, lack of RNase L significantly reduced the migration
of BMMs, particularly in the presence of fresh serum, M-CSF,
GM-CSF, and CCL2. Quantitative analysis revealed that lack of
RNase L reduced 19.4%, 36%, 47%, 24%, and 28% of the
population of migrated cells under the condition without or with
serum, M-CSF, GM-CSF, and CCL2, respectively (Figure 1B).
Obviously, RNase L mostly impacted the M-CSF-induced
macrophage migration although it also contributes to the
chemotrafficking capability of other factors.
RNase L contributes to macrophage endocytosis, but not
phagocytosis
The main function of macrophages in cell physiology and
pathology is their capability of endocytosis and phagocytosis. To
determine the effect of RNase L on macrophage endocytosis and
phagocytosis, RNase L+/+ and 2/2 BMMs were incubated with
either FITC-Dextran 40,000 or FITC-E. coli after the activation by
lipopolysaccharine (LPS). FITC-Dextran is commonly used as a
fluorescent probe to study cell permeability or endocytosis and
FITC-E. coli is employed to analyze macrophage phagocytosis
[25]. Fluorescence of engulfed FITC-Dextran or -E. coli was
observed and analyzed under a microscope after washing to
remove the rest of them in the media and quenching the
extracellular signals. As shown in Figure 2A, deficiency of RNase
L significantly reduced the capability of BMMs to endocytosize
FITC-Dextran 40,000, but had nearly no effect on their
phagocytotic function in engulfing bacteria. The ratio of the
average number of the cells with fluorescence to the total cells
from 8 fields was 61.165.0% in RNase L+/+ BMMs compared to
34.068.3% in RNase L2/2 BMMs in the assay with FITC-
Dextran 40,000. However, the ratio of the fluorescent cells to the
total cells after incubation with FITC-E.coli was 67.465.4% and
64.563.0% in RNase L+/+ and 2/2 BMMs respectively, under the
same condition (Figure 2B). The result indicates that lack of RNase
L in macrophages significantly reduces their endocytotic, but not
phagocytotic function. However, the molecular mechanism
remains largely unknown.
RNase L regulates the cytokine production in
macrophages
It has been well known that macrophages are able to secret a
large number of cytokines, chemokines and growth factors under
stimulation, which in turn regulate their own functions and
promote adaptive immunity [26]. Since our results showed that
RNase L was involved in macrophage migration and endocytosis,
we were intrigued to determine if RNase L regulates the
production of these factors contributing to the function of
macrophages. RNase L +/+ and 2/2 BMMs were treated with
LPS and the secreted products of TNF-a, CCL-2, IL-1b, IL-6, IL-
10 and TGF-b, which are believed to be associated with cell
migration and macrophage functions, in the media were analyzed
by using ELISA. As shown in Figure 3, RNase L is necessary for
the efficient induction of CCL-2 and IL-10, and lack of RNase L
reduced 63% and 78% of the secretory level of CCL-2 and IL-10,
respectively, under stimulation with LPS. However, RNase L only
has a modest effect on the production of TNF-a and TGF-b.
Although the basal level of IL-6 in RNase L+/+ BMMs is
significantly higher (25%) than that in RNase L2/2 BMMs,
Involvement of RNase L in Innate Immunity
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RNase L seemed not to contribute to the induction of IL-6 at all in
the cells by LPS. Interestingly, RNase L apparently inhibited the
production of IL-1b and M-CSF after the cells were treated with
LPS. The secretory level of IL-1b and M-CSF was 2.3- and 1.3-
folds higher respectively in the medium of BMMs deficient RNase
L than that in the medium of wild type BMMs. To confirm the
results, we generated an RNase L deficient Raw 264.7 cell line, a
mouse macrophage cell line, in which RNase L was knocked down
by using RNase L hairpin RNA (ShRNA) lentiviral particles
(Figure S1). RNase L knocked down Raw 264.7 cells were treated
with LPS and the level of these factors described above in the
media was determined by ELISA. As expected, the results were
similar to that obtained in BMMs (Figure S2).
RNase L mediates the Cox-2 expression at its
transcriptional level
To determine if RNase L is involved in regulating the
expression of other proinflammatory genes, we examined the
expression of Cox-2, which catalyzes the production of prosta-
glandins and other eicosanoids, to promote inflammation and is
associated with macrophage function [14,15]. In the experiment,
RNase L+/+ and 2/2 BMMs were treated with LPS and other
stimuli, and the expression of Cox-2 was determined by Western
blot, RT-PCR and qPCR. As shown in the Figure 4A, the
expression of Cox-2 was significantly induced in RNase L +/+
BMMs after the cells were treated with LPS, M-CSF, IFN-a and -
c. However, the induction of Cox-2 was remarkably attenuated in
RNase L2/2 BMMs, suggesting that RNase L impacts the
expression of Cox-2 in the cells induced by LPS. Similar results
were also obtained by using mouse embryonic fibroblasts (MEF)
after treated with LPS and the samples were analyzed by RT-PCR
(Figure 4B). qPCR analysis revealed that the expressing level of
Cox-2 in RNase L +/+ BMMs after treatment with LPS was about
3-fold higher than that in RNase L2/2 BMMs (Figure 4C).
Overall, our results demonstrate that RNase L is involved in the
induction of Cox-2 by LPS. To confirm that the increased
expression level of Cox-2 results in enhancement of the Cox-2
enzymatic activity in the cells, the production of PGE2 was
measured by ELISA. As expected, the production of PGE2 was
Figure 1. Effect of RNase L on macrophage migration. (A) RNase L deficient and wild type BMMs were seeded to the upper chambers of 8 mm
Transwells (black) precoated with 20 mg/ml fibronetin for overnight at 4uC. In the lower chambers, serum-free DMEM, serum-free DMEM with 10%
FBS or 100 ng/ml of M-CSF or GM-CSF or CCL2 were added respectively, and the cells were allowed to migrate at 37uC overnight. The cells on the
filter side of the up chambers were cleaned with a cotton swab and the migrated cells (red) were fixed by 10% formalin for 5 min, followed by
staining with eosin. The unstained grey circles were the pores of the filter. The experiment was repeated three times in duplicate for each treatment.
The photos were from one of the three experiments. (B) The cell numbers were averaged from five fields per transwell in duplicate and present as
Mean 6 SD. *p,0.0001, **p,0.05.
doi:10.1371/journal.pone.0081269.g001
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about 20% higher in the medium of RNase L+/+ BMM in
compared to that in the medium of RNase L2/2 BMM after the
cells were treated with LPS (Figure 4D).
It has been well known that RNase L plays an important role in
RNA turnover after activation by 2-5A during viral infection,
resulting in regulating the production of certain genes [27]. To
determine the level by which RNase L regulates the expression of
Cox-2, the promoter activity of Cox-2 was analyzed in RNase L+/+
and 2/2 cells. RNase L +/+ and 2/2MEFs were transfected with a
reporter construct containing a luciferase gene under the control
of Cox-2 (2860/+127) promoter [28] and the cells were then
treated with or without LPS (1 mg/ml) for 14 h. The luciferase
Figure 2. Role of RNase L in macrophage endocytosis and phagocytosis. (A) RNase L deficient and wild type BMMs were activated with LPS
(0.5 mg/ml) for 48 hours, followed by incubating with FITC-Dextran 40,000 (1 mg/ml) or FITC-E. coli (bacterial to macrophage ratio = 50:1) at 37uC for
1 h. After incubation, the cells were fixed with 4% paraformalhyde for 10 min and washed thoroughly with ice cold phosphate-buffered saline (PBS).
Extracellular fluorescence was quenched by trypan blue. The cells with fluorescence were photographed under a fluorescent microscope. The photos
are shown from one of five experiments. (B) The fluorescent cell numbers were averaged from eight fields per well and present as Mean 6 SD,
*p,0.0001.
doi:10.1371/journal.pone.0081269.g002
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activity was measured by using a luciferase activity assay kit
(Promega, MO) according to the manufacture’s instruction. The
b-galactosidase gene was co-transfected and served as an internal
control for transfection efficiency. Clearly, the promoter activity of
Cox-2 was remarkably higher in the RNase L+/+ cells than that in
the RNase L2/2 cells, suggesting that RNase L may regulate the
expression of Cox-2 at its transcriptional level (Figure 5).
Discussion
The role of RNase L in IFN functions against viral infection and
cell proliferation has been well established. In recent years, RNase
L is found to be involved in apoptosis and autophagy as well
[18,29]. In this study, we demonstrate that RNase L contributes to
macrophage functions including endocytosis, migration, and
cytokine production, which are crucial in innate immunity.
Although it has been reported that RNase L is associated with
innate immunity through regulating the antiviral immune
response [30], this is the first study showing that RNase L impacts
innate immunity by directly mediating the function of immune
cells such as macrophages. The findings significantly expand our
horizon of understanding the basic cellular functions and signaling
pathways of RNase L.
Macrophage migration is one of the major characteristics of
macrophage functions involved in several pathological situations
including cancer, neurodegenerative disorders and chronic
inflammation. It has been believed that macrophages can use
either the amoeboid (protease-independent) or the mesenchymal
Figure 3. RNase L regulates the expression of cytokines and chemokines. RNase L deficient and wild type BMMs were treated with 1 mg/ml
of LPS for 14 h. The secretory level of certain cytokines and chemokines in the media was measured by using an ELISA kit for each of the analyzers.
Experiments were performed two times in triplicates. Data are presented as Mean 6SD. *p,0.0001, **p,0.05.
doi:10.1371/journal.pone.0081269.g003
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(protease-dependent) migration mode depending on the environ-
mental constraints to migrate to the site of infection and targeting
spots [31]. Macrophages are recruited to specific sites by
chemotaxis which directs cell migration towards chemoattractant
gradients. The cell senses a gradient and moves by extending
actin-rich protrusions towards the chemoattractant propelled by
actin-myosin mediated contractions [32]. RNase L seems to play a
critical role in the M-CSF induced cell migration and deficiency of
RNase L in macrophages reduced about 50% of migrated cell
population. M-CSF is a pleiotropic macrophage growth factor,
which contributes to the differentiation, survival, proliferation and
motility of mononuclear cells. M-CSF regulates the function of
macrophages through activation of the tyrosine kinase receptor
CSF-1R, leading to phosphorylation of downstream molecules and
resulting in activation of several important signaling transduction
pathways including PI-3K. PI3K signals primarily through Akt to
activate Rac and inactivate Rho, to stimulate actin polymeriza-
tion, cytoskeletal remodeling and cell adhesion, subsequently
promote cell moving [33]. Although we have not determined if
RNase L is involved in M-CSF-induced macrophage migration
Figure 4. RNase L regulates the expression of Cox-2. RNase L deficient and wild type BMMs were treated with 1 mg/ml of LPS, 1,000 units/ml of
IFN-a, 500 units/ml of IFN-c, and 100 ng/ml of M-CSF for 14 h. The expression of Cox-2 was determined by Western blot analysis using a monolocnal
antibody against mouse Cox-2 (A). RNase L wild type and deficient MEFs were treated with 1 mg/ml of LPS for 14 h. Total RNAs were isolated by using
the Trizol Reagent (Invitrogen, CA). The expression of Cox-2, TNF-a, IL-6 and IL-1b was determined by RT-PCR (B). The expression of Cox-2 was
measured by real-time PCR (C), which was performed twice in triplicate; the fold change from one of the experiments is present as Mean 6SD,
*p,0.05. The production of PGE2 in the media culturing the two types of BMMs treated with LPS as described above was analyzed by ELISA (D).
Experiments were performed twice in triplicates. Data are presented as Mean 6SD, *p,0.05.
doi:10.1371/journal.pone.0081269.g004
Involvement of RNase L in Innate Immunity
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through impacting on the PI-3K pathway, our unpublished result
indeed revealed that phosphorylation of Akt in RNase L deficient
MEFs and primary hepatocytes was remarkably inhibited under
stimulation with insulin, suggesting that blockage of the PI-3K
pathway may be the cause to reduce the migrated population of
RNase L deficient macrophages. The role of RNase L in CCL2 -
and GM-CSF –induced macrophages remains to be elucidated.
Phagocytosis and endocytosis by which macrophages, dendritic
cells and other myeloid phagocytes internalize diverse microbes
and particulate targets are the vital mechanism of both innate and
adaptive immunities. The mechanisms mediating the internaliza-
tion of target particles are distinct, depending on a specific target
and its location. A variety of different receptors on the surface of
these phagocytes are able to sense and recognize their cognate
ligands expressed on microorganisms and soluble matter, and
subsequently ingest them by a phagocytic or endocytic manner
[3,5]. These processes are essential for macrophage antigen
presentation to activate T-cells, and mostly promote the expression
of proinflammtory cytokines and chemokines, which orchestrate
local and systemic inflammatory responses, leading to the
development of adaptive immunity. Interestingly, RNase L seems
to be involved in only engulfing dextran, not E. coli bacteria by
macrophages, suggesting that RNase L may contribute to the
function of a specific receptor responsible for intake of certain
types of particulates. Many factors are associated with efficacy of
phagocytosis and endocytosis of macrophages, for example, the
size and other physical properties, such as geometry and
topography of a target molecule can influence its delivery into
the cells [34]. However, receptors are believed to play a critical
role in the phagocytic uptake of target particles. It has been known
that FITC-Dextran is mainly taken up through the mannose
receptor, a C-type lectin, into macrophages [30,31]. Most recently,
a study has revealed that the mannose receptor is required for the
endocytic uptake of influenza virus into macrophages [35]. RNase
L is a well-known antiviral protein mediating IFN functions in vitro
and in vivo, and also found to be located in cytoskeleton although
its role in the cell membrane remains largely unknown [36]. Our
results suggest that RNase L may function as a component
necessary for the entry of certain types of virus into a cell, a role
similar to CD4 and chemokine co-receptors such as CXCR4 or
CCR5 in HIV infection [37], which subsequently trigger the
apoptotic cascade, leading to the clearance of virus although this
hypothesis needs to be further demonstrated. In addition, mannose
receptors mediate phagocytosis of a variety of bacterium strains
such as Candida albicans, Zymosan, Pneumocystis carinii, Klebsiella, and
mycobacteria, as well as other pathogens [38–43]. Thus, there was no
obvious difference in phagocytosis of FITC-E. coli between RNase
L+/+ and 2/2 macrophages does not exclude the possibility that
RNase L may mediate the process for the cell uptake of other types
of microorganisms.
It has been believed that RNase L regulates the production of
several genes such as TNF-a, IL-1b, and IFN-b during viral and
bacterial infection [30,44]. In this study, we determined the
secretory level of TNF-a, CCL-2, IL-1b, IL-6, IL-10, TGF-b, and
M-CSF, which may be associated with cell migration and
macrophage functions, and found that RNase L was necessary
for the efficient expression of CCL2 and IL-10, and modestly
promoted the induction of TNF-a and TGF-b in the presence of
LPS. In contrast, RNase L seemed to inhibit production IL-1b and
M-CSF induced by LPS. It is surprising that deficiency of RNase L
resulted in a 5-fold reduction of the expression of IL-10, a cytokine
with broad anti-inflammatory properties involved in the patho-
genesis of various diseases [45], in macrophages after treatment
with LPS. On the other hand, the expression level of Cox-2 is 3-
fold higher in RNase L+/+ cells than that in RNase L 2/2 cells
under the treatment with LPS and other stimuli. Our results
showed that RNase L may play a dual role in immunity by
regulating the expression of proinflammatory and anti-inflamma-
tory genes under a specific microenvironment although the
physiological significance of the event needs to be further
investigated. The promoter analysis revealed that RNase L
regulates the expression of Cox-2 at its transcriptional level, but
how and what is the molecular mechanism are completely
unknown. RNase L has 9 typical anykrin-repeats and a conserved
kinase domain in its protein structure. Hereby, it is possible that
RNase L may directly interact with or phosphorylate some
transcriptional factors to regulate the expression of Cox-2 in the
cells, and this hypothesis is under investigating in the laboratory.
Taken together, our findings provide new insight into the
contribution of RNase L to macrophage functions, and suggest a
novel role of RNase L in immunity.
Materials and Methods
Cell Culture
BMMs were generated from the bone marrow cells of RNase L
deficient and wild type C57BL/6 mice (a generous gift from Dr.
Robert Silverman, Cleveland Clinic) by using a modification of a
previously reported method [39]. Briefly, bone marrow cells were
isolated from the femurs of mice by repeated flushing of the bone
shaft with cold medium and cultured in RPMI 1640 medium
(Cleveland Clinic, Cleveland, OH) supplemented with 10 ng/ml
recombinant murine M-CSF (Shenandoah Biotechnology, War-
wick, PA), 20% fetal bovine serum (VWR, Bridge Port, NJ), and
10% L929 cells-conditioned medium (LCM). Macrophages were
ready after 7 days culture under the condition. To assess
macrophage endocytosis and phagocytosis capability, macrophag-
es were activated with LPS (0.5 mg/ml) for 48 h before the
Figure 5. Promoter activity analysis of Cox-2. RNase L deficient
and wild type MEFs were transfected with the Cox-2 promoter (2860/
+127)-pGL3 luciferase reporter construct (20 mg) together with a
plasmid containing a b-galactosidase gene (1 mg) by using lipofecta-
mine 2000 (Invitrogen, CA) according to the manufacture’s instruction.
After transfection, the cells were allowed to recover for 24 h and
subsequently treated with or without LPS (1 mg/ml) for 14 h. The
activity of luciferase and b-galactosidase was assayed as described in
Materials and Methods. The experiments were performed twice in
triplicates and the result are present as Mean 6 SD. *p,0.002.
doi:10.1371/journal.pone.0081269.g005
Involvement of RNase L in Innate Immunity
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experiments. This study was carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of Cleveland State University (Permit Number:
21111-ZHO-AS). All efforts were made to reduce suffering. Mice
were under CO2 for 5 min and then dislocated their neck before
isolation of bone marrow cells.
Knocking down of RNase L in RAW264.7 cells
RAW264.7 cells were cultured in a 12-well plate to 50%
confluent on the day of infection. A complete medium with
polybrene (Santa Cruz Biotechnology, Dallas, TX) at a final
concentration of 5 mg/ml was added in each well and the cells
then were infected by directly adding mouse RNase L shRNA or
empty lentiviral particles (Santa Cruz Biotechnology, Dallas, TX).
After incubation overnight, the culture medium was replaced with
a fresh complete medium. Clones were selected by culturing the
infected cells in the medium containing puromiycin (10 mg/ml)
and the expression of RNase L in the clones was analyzed by
Western blot.
Endocytosis and phagocytosis assay
Endocytosis and phagocytosis of macrophages were assessed by
using FITC-Dextran 40,000 (Sigma, St. Louis, MO) and FITC-E.
coli particles (Invitrogen, Grand Island, NY) respectively. The cells
were washed twice with cold PBS after macrophages were
activated with LPS (0.5 mg/ml) for 48 hours, and incubated in
fresh RPMI 1640 medium (Cleveland Clinic, Cleveland, OH)
containing 10% FBS and 25 mM Hepes with FITC-Dextran
40,000 (1 mg/ml) or FITC-E. coli (bacterial to macrophage
ratio = 50:1) at 37uC for 1 h. Negative control groups were
incubated on ice. After incubation, the cells were fixed with 4%
paraformalhyde for 10 min and fluorescence of extracellular
particles was thoroughly washed out by using ice cold phos-
phate-buffered saline (PBS) and quenched with 1–2 ml 0.02%
trypan blue for 3 min. A cold anti-fade reagent (Invitrogen, Grand
Island, NY) was used as a mounting solution and slides were
observed under a microscope.
Macrophage migration assay
BMMs (26105) in the serum free medium were seeded to the
upper chambers of 8 mm Transwells (ThinCertTM-24 Well)
(VWR, Bridge Port, NJ) precoated with 20 mg/ml fibronetin for
overnight at 4uC. In the lower chambers, serum-free DMEM,
serum-free DMEM supplemented with 10% FBS or 100 ng/ml of
M-CSF or GM-CSF or CCL2 (Shenandoah Biotechnology,
Warwick, PA) were added respectively, and the cells were allowed
to migrate at 37uC overnight. At the end of the assay, the filter side
of the up chamber was cleaned with a cotton swab and the
migrated cells were fixed by 10% formalin for 5 min and then
stained with eosin. Five fields per transwell were photographed at
1006 magnification under a microscope and the cells in each
image were counted.
Western blot analysis
After treatment, cells were washed twice with ice-cold PBS and
collected with a scraper. The cytoplasmic extracts were prepared
by suspension of the cell pellets in the NP-40 lysis buffer (10 mM
Tris-HCl, pH8.0, 5 mMMg(OAc)2, 90 mM KCl, 0.2 mM PMSF,
100 units/ml aprotinin, 10 mg/ml leupeptin and 2% NP-40). After
centrifugation at 10,0006g in a microcentrifuge at 4uC for
10 min, the cell extracts (100 mg per sample) were fractionated on
SDS-10% polyacrylamide gels and transferred to PVDF mem-
branes (Millipore, Billerica, MA). The membranes were blocked
with 5% nonfat milk in PBS containing 0.02% sodium azide and
0.2% (v/v) Tween 20, and incubated with different primary
antibodies for 1 h at room temperature. The membranes were
then washed with PBS containing 0.2% (v/v) Tween 20 and
incubated with specific secondary antibodies conjugated with
horseradish peroxidase (Cell Signaling, Billerica, MA) for 1 h at
room temperature. After washing, the proteins were detected by a
chemiluminescent method according to the manufacturer’s
specification (Pierce, Rockford, IL).
RT-PCR and real time PCR
The cells were treated with 1 mg/ml of LPS for 14 h and the
total RNAs were isolated by using the Trizol reagent (Invitrogen,
Grand Island, NY). RT-PCR was performed by using the
Superscript One-Step RT-PCR kit (Invitrogen, Grand Island,
NY). The condition for cDNA synthesis is: 1 cycle at 55uC for
30 min, and 1 cycle at 94uC for 2 min. PCR amplification was
performed by using the following condition: denaturing at 94uC
for 15 sec, annealing at 55uC for 30 sec, and extension at 72uC for
1 min, for 25 cycles, then an additional cycle at 72uC for 8 min.
The PCR primers are listed below. Cox-2 sense: 59 GCA AAT
CCT TGC TGT TCC AAT C 39, antinsense: 59 GGA GAA
GGC TTC CCA GCT TTT G 39; TNF-a sense: 59 GAT CTC
AAA GAC AAC CAA CTA GTG 39, antisense: 59 CTC CAG
CTG GAA GAC TCC TCC CAG 39; IL-6 sense: 59 CAT GTT
CTC TGG GAA ATC GTG G 39, antisense: 59 AAC GCA CTA
GGT TTG CCG AGT A 39; IL-1b sense: 59 GGG ATG ATG
ATG ATA ACC TG 39, antisense: 59 TTG TCG TTG CTT
GGT TCT CCT 39; b-actin sense: 59TCA CCC ACA TG TGC
CCA TCT ACG A39, antisense: 59 CAG CGC AAC CGC TCA
TTG CCA ATG G39. qPCR for Cox-2 was performed by using
QuantiTect SYBR Green PCR kit (Qiagen, Valencia, CA) in a
Thermal Cycler (Model: DNA Engine 2/Opticon2).
Enzyme-linked immunosorbent assay (ELISA)
Cytokines and other factors in the media culturing macrophages
were measured by ELISA with commercial available kits
(eBioscience, San Diego, CA and R&D Systems, Minneapolis,
MN). Briefly, RNase L deficient and wild type BMMs were treated
with 1 mg/ml of LPS for 14 h, and the media were collected and
stored in a 280uC freezer before analysis. For the assays, flat
bottom 96-well ELISA plates were coated with a capture antibody
at 4uC according to manufacturer’s instruction. After overnight
incubation at 4uC, the plates were washed three times and blocked
with the blocking buffer provided in the kit, and then incubated
with standards and cell culture medium samples for 2 h at room
temperature. After washing the plates, a specific biotinylated
antibody was added to each well and incubated for 1 h, followed
by washing and 30 min incubation with avidin peroxidase. Then,
substrates containing 3, 39 5, 59-tetramethylbenzidine (TMB) and
hydrogen peroxide were added, and the reaction was terminated
by adding 50 ml of phosphoric acid after 30 min. Plates were read
at 450 nm in a 96-well LD 400 C microplate reader (Beckman
Coulter, Fullerton, CA).
Luciferase reporter assay
The Cox-2 promoter (2860/+127)-pGL3 luciferase reporter
construct (20 mg) provided by Dr. Narkunaraja Shanmugam
(Division of Diabetes, Beckman Research Institute of the City of
Hope) was transfected into RNase L+/+ and 2/2 MEFs together
with a plasmid containing a b-galactosidase gene (1 mg) by using
lipofectamine 2000 (Invitrogen, Grand Island, NY) according to
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the manufacture’s instruction. After transfection, the cells were
allowed to recover for 24 h and subsequently treated with or
without LPS (1 mg/ml) for 14 h. The cells were washed twice with
PBS and harvested for luciferase and b-galactosidase activity
assays. Briefly, the cell extracts (20 ml/sample) were added to the
wells of a 96-well microtiter plate (Dynstech, Inc., Mclean, VA)
and mixed with 50 ml luciferase assay substrates. The results were
determined in a luminometer (Perkin Elmer, Waltham, MA). To
monitor b-galactosidase activity, the cell extracts were incubated
with the assay buffer (200 mM sodium phosphate buffer, pH 7.3,
2 mM MgCl2, 100 mM b-mercaptoethanol) containing the
substrate O-nitrophenyl-b-D-galactopyranoside (ONPG) (Sigma,
St. Louis, MO) at 37uC until a yellow color appeared, and the
reaction was terminated by addition of sodium carbonate. The
absorbance at 420 nm was measured by spectrophotometry.
Supporting Information
Figure S1 Knocking down of RNase L in mouse
macrophages. RAW264.7 cells were infected by mouse RNase
L shRNA or empty lentiviral particles in the medium containing
5 mg/ml of polybrene. Clones were selected by culturing the
infected cells in the medium containing puromiycin (10 mg/ml)
and the expression of RNase L in the clones was analyzed by
Western blot using a poly clonal antibody to mouse RNase L. b-
actin was used to normalize the protein loading.
(TIF)
Figure S2 RNase L regulates the expression of cytokines
and chemokines in macrophages. RNase L knocking down
(Clone 106) and wild type Raw264.7 cells were treated with 1 mg/
ml of LPS for 14 h. The secretory level of certain cytokines and
chemokines in the media was measured by using an ELISA kit for
each of the analyzers. Experiments were performed two times in
triplicates. Data are presented as mean 6SD. *p,0.001,
**p,0.05.
(TIF)
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